Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXX5I7
|
||||
| Drug Name |
(S)-1-(1H-Indol-4-yloxy)-3-[(4S,6R)-2-methyl-4-(4-trifluoromethyl-benzo[b]thiophen-2-yl)-piperidin-1-yl]-propan-2-ol
|
||||
| Synonyms |
CHEMBL80777
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H27F3N2O2S
|
||||
| Canonical SMILES |
C[C@H]1C[C@@H](CCN1C[C@H](O)COc2cccc3[nH]ccc23)c4cc5c(cccc5s4)C(F)(F)F
|
||||
| InChI |
InChI=1S/C26H27F3N2O2S/c1-16-12-17(25-13-20-21(26(27,28)29)4-2-7-24(20)34-25)9-11-31(16)14-18(32)15-33-23-6-3-5-22-19(23)8-10-30-22/h2-8,10,13,16-18,30,32H,9,11-12,14-15H2,1H3/t16-,17+,18-/m0/s1
|
||||
| InChIKey |
IXVXZUNOBJNUJF-KSZLIROESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.